Try our Advanced Search for more refined results

Expert Analysis

1st Circ. Charts Conservative Post-Actavis Course In Loestrin

Law360, New York (February 26, 2016, 10:27 AM EST) -- In its Feb. 22, 2016 unanimous panel decision in the Loestrin 24 Fe Antitrust Litigation,[1] the U.S. Court of Appeals for the First Circuit became the second federal appellate court since the U.S. Supreme Court's seminal decision in Federal Trade Commission v. Actavis[2] to wrestle with the knotty problem of "reverse payment" settlements of Hatch-Waxman Act-related[3] pharmaceutical patent infringement claims.[4] Although the court of appeals sought to limit its decision to a narrow legal question, the reader familiar with this growing body of litigation might take five points away from the decision....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!